Cargando…

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study

BACKGROUND: Prostate cancer (PrCa) is the second most prevalent malignancy in men worldwide. Observational studies have linked the use of low-density lipoprotein cholesterol (LDL-c) lowering therapies with reduced risk of PrCa, which may potentially be attributable to confounding factors. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Si, Yarmolinsky, James, Gill, Dipender, Bull, Caroline J., Perks, Claire M., Davey Smith, George, Gaunt, Tom R., Richardson, Tom G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810198/ https://www.ncbi.nlm.nih.gov/pubmed/36595504 http://dx.doi.org/10.1371/journal.pmed.1003988

Ejemplares similares

Genetically proxied lean mass and risk of Alzheimer’s disease: mendelian randomisation study
por: Daghlas, Iyas, et al.
Publicado: (2023)

Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
por: Yarmolinsky, James, et al.
Publicado: (2023)

Systematic comparison of Mendelian randomisation studies and randomised controlled trials using electronic databases
por: Sobczyk, Maria K, et al.
Publicado: (2023)

Evaluating and implementing block jackknife resampling Mendelian randomization to mitigate bias induced by overlapping samples
por: Fang, Si, et al.
Publicado: (2022)

Mendelian randomization applied to pharmaceutical use: the case of metformin and lung cancer
por: Yarmolinsky, James, et al.
Publicado: (2020)

Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization
por: Taylor, Kurt, et al.
Publicado: (2019)

PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study
por: Lyall, Donald M., et al.
Publicado: (2021)

A transcriptome-wide Mendelian randomization study to uncover tissue-dependent regulatory mechanisms across the human phenome
por: Richardson, Tom G., et al.
Publicado: (2020)

Genetically proxied impaired GIPR signaling and risk of 6 cancers
por: Rogers, Miranda, et al.
Publicado: (2023)

Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study
por: Yuan, Shuai, et al.
Publicado: (2021)

PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
por: Schmidt, Amand F, et al.
Publicado: (2017)

Integrating Mendelian randomization and multiple-trait colocalization to uncover cell-specific inflammatory drivers of autoimmune and atopic disease
por: McGowan, Lucy M, et al.
Publicado: (2019)

Drug target Mendelian randomisation: are we really instrumenting drug use? Reply to Anderson EL, Williams DM [letter]
por: Zheng, Jie, et al.
Publicado: (2023)

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
por: Yarmolinsky, James, et al.
Publicado: (2022)

Mendelian Randomization Analysis Identifies CpG Sites as Putative Mediators for Genetic Influences on Cardiovascular Disease Risk
por: Richardson, Tom G., et al.
Publicado: (2017)

Mendelian randomization does not support serum calcium in prostate cancer risk
por: Yarmolinsky, James, et al.
Publicado: (2018)

Sparse dimensionality reduction approaches in Mendelian randomisation with highly correlated exposures
por: Karageorgiou, Vasileios, et al.
Publicado: (2023)

Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug‐Target Mendelian Randomization Study
por: Bell, Andrew S., et al.
Publicado: (2022)

Separating the effects of childhood and adult body size on inflammatory arthritis: a Mendelian randomisation study
por: Zhao, Sizheng Steven, et al.
Publicado: (2022)

Commentary: Mendelian randomization analysis identifies circulating vitamin D as a causal risk factor for ovarian cancer
por: Bull, Caroline J, et al.
Publicado: (2016)

Leverage of genetic variants proxying smoking intensity to explore the broad health consequences of smoking
por: Gill, Dipender
Publicado: (2020)

Systematic Mendelian randomization framework elucidates hundreds of CpG sites which may mediate the influence of genetic variants on disease
por: Richardson, Tom G, et al.
Publicado: (2018)

Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study
por: Richardson, Tom G, et al.
Publicado: (2020)

Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization
por: Katikireddi, Srinivasa Vittal, et al.
Publicado: (2017)

Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis
por: Yarmolinsky, James, et al.
Publicado: (2018)

Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer
por: Sun, Lulu, et al.
Publicado: (2022)

Morning Cortisol and Circulating Inflammatory Cytokine Levels: A Mendelian Randomisation Study
por: Rajasundaram, Skanda, et al.
Publicado: (2022)

Establishing plausibility of cardiovascular adverse effects of immunotherapies using Mendelian randomisation
por: Le, Nhu Ngoc, et al.
Publicado: (2023)

Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
por: Richardson, Tom G., et al.
Publicado: (2022)

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
por: Benn, Marianne, et al.
Publicado: (2017)

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
Publicado: (2017)

The evolution of mendelian randomization for investigating drug effects
por: Gill, Dipender, et al.
Publicado: (2022)

Mendelian randomisation analysis of circulating adipokines and C‐reactive protein on breast cancer risk
por: Robinson, Timothy, et al.
Publicado: (2020)

Genetic variations in HMGCR and PCSK9 and kidney function: a Mendelian randomization study
por: Park, Sehoon, et al.
Publicado: (2023)

Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression
por: Mitchell, Ruth E., et al.
Publicado: (2023)

Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy
por: Kraaijenhof, Jordan M., et al.
Publicado: (2023)

Appraisal of the causal effect of plasma caffeine on adiposity, type 2 diabetes, and cardiovascular disease: two sample mendelian randomisation study
por: Larsson, Susanna C, et al.
Publicado: (2023)

Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
por: Richardson, Tom G., et al.
Publicado: (2020)

Standardizing the reporting of Mendelian randomization studies
por: Au Yeung, Shiu Lun, et al.
Publicado: (2023)

Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia
por: Larsson, Susanna C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hub58kj7s83jmfundkvt788tvc